Listen to the article
In a significant case of Medicare fraud, a Worcester-based pharmacy has reached a settlement with federal authorities over allegations that it systematically billed the government healthcare program for medications it never actually dispensed to patients.
Trang Pharmacy, located at 456 Park Avenue in Worcester, Massachusetts, has agreed to pay $750,000 to resolve claims that it violated the False Claims Act, according to an announcement made Thursday by the U.S. Attorney’s Office of Massachusetts.
The pharmacy, owned by Thu Trang Le Chang, admitted to submitting fraudulent claims to Medicare Part D—the federal program that covers prescription drug costs for Medicare enrollees—over a ten-year period from January 2016 through January 2026. Federal investigators determined the business could not provide evidence that it had ever purchased nine different medications for which it billed the government program.
This case highlights ongoing concerns about fraud within the Medicare system, particularly in its prescription drug program. Medicare Part D, implemented in 2006, has been vulnerable to various schemes that collectively cost taxpayers billions annually, according to healthcare fraud experts.
“Pharmacies that bill Medicare for medications they never dispensed are essentially stealing from taxpayers and undermining the integrity of essential healthcare programs,” said a healthcare compliance attorney familiar with such cases, who spoke on condition of anonymity.
The investigation that led to the settlement was a joint effort between the U.S. Attorney’s Office of Massachusetts and the Justice Department’s Civil Division, Commercial Litigation Branch, Fraud Section. These agencies routinely collaborate to investigate healthcare fraud allegations nationwide.
Medicare fraud has been a persistent issue for the federal government, with the Department of Health and Human Services estimating that improper payments within Medicare programs total more than $60 billion annually. Pharmacy fraud schemes represent a significant portion of these losses.
The False Claims Act, under which Trang Pharmacy was charged, is one of the government’s primary tools for combating healthcare fraud. The law allows for substantial penalties against those who knowingly submit false claims to the government, including potential damages of up to three times the amount fraudulently obtained.
For small independent pharmacies like Trang, such settlements can be financially devastating. However, industry analysts note that the $750,000 settlement suggests the fraudulent billing may have been substantial, as settlements typically represent a fraction of the total fraudulent claims identified.
This case comes amid increased scrutiny of prescription drug billing practices. The Centers for Medicare & Medicaid Services has been implementing more sophisticated analytics to detect unusual billing patterns, which likely contributed to identifying the irregularities at Trang Pharmacy.
Independent pharmacies across Massachusetts have faced significant challenges in recent years, with many struggling to remain profitable amid thin margins and competition from large chain pharmacies and mail-order prescription services. However, experts emphasize that financial pressures never justify fraudulent billing practices.
The settlement agreement did not specify whether Trang Pharmacy would face additional penalties beyond the monetary payment, such as exclusion from Medicare programs or enhanced compliance requirements. Such measures are common in cases involving deliberate healthcare fraud.
Local Worcester residents who use Trang Pharmacy may now face decisions about whether to continue filling their prescriptions at the establishment following these revelations. The case serves as a reminder of the importance of oversight in healthcare billing and the serious consequences that can result from fraudulent practices in the industry.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
13 Comments
A $750,000 settlement is a substantial penalty for this pharmacy’s alleged misconduct. It’s critical that government healthcare programs maintain robust anti-fraud measures to protect taxpayer funds and patient trust.
Allegations of systematically billing Medicare for medications never dispensed is very concerning. This case underscores the importance of strong oversight and accountability within the Medicare Part D program.
You’re right. Rooting out fraud in Medicare Part D should be an ongoing focus to ensure the program’s integrity and sustainability. Rigorous auditing and enforcement are key.
This settlement highlights the need for continued vigilance against fraud in government healthcare programs like Medicare Part D. Maintaining trust and protecting patient access to necessary medications should be top priorities.
This is a concerning case of alleged Medicare fraud by a pharmacy. It’s crucial that healthcare providers maintain integrity and accountability when billing government programs. Hopefully this settlement sends a strong message against such fraudulent practices.
Agreed. Fraud in Medicare Part D is a serious issue that needs to be addressed. Rigorous oversight and enforcement are vital to protect taxpayer funds and patient access to necessary medications.
Fraudulent billing practices that divert Medicare funds away from patient care are unacceptable. This $750K settlement sends an important message, but more work is needed to strengthen program integrity and oversight.
Agreed. Combating fraud in Medicare Part D requires a multi-faceted approach, including robust auditing, tough enforcement, and ongoing reforms to close vulnerabilities in the system.
This case highlights the need for closer scrutiny of Medicare Part D claims. Fraudulent billing practices can divert scarce resources away from providing essential care. Ongoing reforms to strengthen program oversight are important.
Absolutely. Combating fraud in Medicare Part D should be a top priority to ensure the program’s long-term sustainability and patient access to necessary medications.
Billing for medications that were never dispensed is egregious abuse of the Medicare system. This $750K settlement is a significant penalty, but ongoing vigilance is needed to root out these kinds of fraudulent schemes.
You’re right. Medicare Part D is a complex program vulnerable to abuse. Stronger auditing and transparency measures could help prevent future incidents like this.
It’s good to see federal authorities taking action against this pharmacy’s alleged false claims. Maintaining the integrity of government healthcare programs is crucial for protecting both taxpayers and patients.